US 7256004
Variants of humanized anti-carcinoma monoclonal antibody CC49
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 7256004 (Variants of humanized anti-carcinoma monoclonal antibody CC49) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K49/0002, A61K51/1045